BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27865823)

  • 1. Gut hormones and gut microbiota: implications for kidney function and hypertension.
    Afsar B; Vaziri ND; Aslan G; Tarim K; Kanbay M
    J Am Soc Hypertens; 2016 Dec; 10(12):954-961. PubMed ID: 27865823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension as a Metabolic Disorder and the Novel Role of the Gut.
    Tanaka M; Itoh H
    Curr Hypertens Rep; 2019 Jun; 21(8):63. PubMed ID: 31236708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal inhibition of the Na+/H+ exchanger 3 prevents cardiorenal damage in rats and inhibits Na+ uptake in humans.
    Spencer AG; Labonte ED; Rosenbaum DP; Plato CF; Carreras CW; Leadbetter MR; Kozuka K; Kohler J; Koo-McCoy S; He L; Bell N; Tabora J; Joly KM; Navre M; Jacobs JW; Charmot D
    Sci Transl Med; 2014 Mar; 6(227):227ra36. PubMed ID: 24622516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic inhibition of intestinal sodium uptake: a gut centric approach to sodium management.
    Spencer AG; Greasley PJ
    Curr Opin Nephrol Hypertens; 2015 Sep; 24(5):410-6. PubMed ID: 26197202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium, hypertension, and the gut: does the gut microbiota go salty?
    Smiljanec K; Lennon SL
    Am J Physiol Heart Circ Physiol; 2019 Dec; 317(6):H1173-H1182. PubMed ID: 31585045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of intestinal barrier and microbiota in chronic kidney disease.
    Sabatino A; Regolisti G; Brusasco I; Cabassi A; Morabito S; Fiaccadori E
    Nephrol Dial Transplant; 2015 Jun; 30(6):924-33. PubMed ID: 25190600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota, hypertension and chronic kidney disease: Recent advances.
    Sircana A; De Michieli F; Parente R; Framarin L; Leone N; Berrutti M; Paschetta E; Bongiovanni D; Musso G
    Pharmacol Res; 2019 Jun; 144():390-408. PubMed ID: 29378252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.
    Yang T; Richards EM; Pepine CJ; Raizada MK
    Nat Rev Nephrol; 2018 Jul; 14(7):442-456. PubMed ID: 29760448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiome and kidney disease: a bidirectional relationship.
    Al Khodor S; Shatat IF
    Pediatr Nephrol; 2017 Jun; 32(6):921-931. PubMed ID: 27129691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Myth of Water and Salt: From Aquaretics to Tenapanor.
    Visconti L; Cernaro V; Calimeri S; Lacquaniti A; De Gregorio F; Ricciardi CA; Lacava V; Santoro D; Buemi M
    J Ren Nutr; 2018 Mar; 28(2):73-82. PubMed ID: 29146141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NHE3-mediated Sodium Absorption in the Gut Reduced Cardiac End-organ Damage Without Deteriorating Renal Function in Obese Spontaneously Hypertensive Rats.
    Linz B; Hohl M; Reil JC; Böhm M; Linz D
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):225-31. PubMed ID: 26727380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.
    Mafra D; Lobo JC; Barros AF; Koppe L; Vaziri ND; Fouque D
    Future Microbiol; 2014; 9(3):399-410. PubMed ID: 24762311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of resistant hypertension in chronic kidney disease.
    Campese VM
    Semin Nephrol; 2014; 34(5):571-6. PubMed ID: 25416666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota in hypertension.
    Jose PA; Raj D
    Curr Opin Nephrol Hypertens; 2015 Sep; 24(5):403-9. PubMed ID: 26125644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.
    Pan W; Kang Y
    Int Urol Nephrol; 2018 Feb; 50(2):289-299. PubMed ID: 28849345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond gut feelings: how the gut microbiota regulates blood pressure.
    Marques FZ; Mackay CR; Kaye DM
    Nat Rev Cardiol; 2018 Jan; 15(1):20-32. PubMed ID: 28836619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease.
    Onal EM; Afsar B; Covic A; Vaziri ND; Kanbay M
    Hypertens Res; 2019 Feb; 42(2):123-140. PubMed ID: 30504819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of gut microbiota on kidney function and pathogenesis.
    Mahmoodpoor F; Rahbar Saadat Y; Barzegari A; Ardalan M; Zununi Vahed S
    Biomed Pharmacother; 2017 Sep; 93():412-419. PubMed ID: 28654798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota in kidney disease and hypertension.
    Antza C; Stabouli S; Kotsis V
    Pharmacol Res; 2018 Apr; 130():198-203. PubMed ID: 29496593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-talk between gut microbiome, salt and hypertension.
    Naqvi S; Asar TO; Kumar V; Al-Abbasi FA; Alhayyani S; Kamal MA; Anwar F
    Biomed Pharmacother; 2021 Feb; 134():111156. PubMed ID: 33401080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.